We are live on ! Find out more
FGP

Freestone Grove Partners Portfolio holdings

AUM $14.2B
1-Year Est. Return 24.58%
This Fund
S&P 500
This Quarter Est. Return
+0.58%
1 Year Est. Return
+24.58%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$9.71B
AUM Growth
+$1.55B
Cap. Flow
+$1.78B
Cap. Flow %
18.36%
Top 10 Hldgs %
15.65%
Holding
829
New
260
Increased
164
Reduced
136
Closed
261

Top Buys

Rank Stock Value
1
VOO icon
Vanguard S&P 500 ETF
VOO
+$495M
2
GD icon
General Dynamics
GD
+$178M
3
AMZN icon
Amazon
AMZN
+$130M
4
WWD icon
Woodward
WWD
+$102M
5
LRCX icon
Lam Research
LRCX
+$97.7M

Sector Composition

Rank Sector Weight
1 Financials 19.29%
2 Technology 17.35%
3 Industrials 13.36%
4 Healthcare 11.97%
5 Consumer Discretionary 10.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SUI icon
776
Sun Communities
SUI
$14.8B
-5,821
Closed -$716K
SWBI icon
777
Smith & Wesson
SWBI
$645M
-27,365
Closed -$277K
TAP icon
778
Molson Coors Class B
TAP
$7.51B
-521,858
Closed -$29.9M
TARS icon
779
Tarsus Pharmaceuticals
TARS
$2.56B
-7,921
Closed -$439K
TECH icon
780
Bio-Techne
TECH
$11.2B
-417,143
Closed -$30M
TER icon
781
Teradyne
TER
$58.5B
-64,791
Closed -$8.16M
TGT icon
782
Target
TGT
$61.1B
-2,425
Closed -$328K
TGTX icon
783
TG Therapeutics
TGTX
$8.5B
-7,433
Closed -$224K
TKR icon
784
Timken Company
TKR
$9.79B
-3,620
Closed -$258K
TKO icon
785
TKO Group
TKO
$13.5B
-1,792
Closed -$255K
TMDX icon
786
Transmedics
TMDX
$2.46B
-3,865
Closed -$241K
TMHC icon
787
Taylor Morrison
TMHC
$6.67B
-8,328
Closed -$510K
TNDM icon
788
Tandem Diabetes Care
TNDM
$1.16B
-181,124
Closed -$6.52M
TPG icon
789
TPG
TPG
$6.74B
-261,907
Closed -$16.5M
TREE icon
790
LendingTree
TREE
$550M
-10,585
Closed -$410K
TRMB icon
791
Trimble
TRMB
$11.7B
-55,180
Closed -$3.9M
TRNO icon
792
Terreno Realty
TRNO
$7.62B
-4,324
Closed -$256K
TRUP icon
793
Trupanion
TRUP
$1.03B
-161,327
Closed -$7.78M
TS icon
794
Tenaris
TS
$29B
-436,254
Closed -$16.5M
TSLA icon
795
Tesla
TSLA
$1.26T
-4,710
Closed -$1.9M
TVTX icon
796
Travere Therapeutics
TVTX
$5.27B
-25,521
Closed -$445K
TXRH icon
797
Texas Roadhouse
TXRH
$12.5B
-1,589
Closed -$287K
TYL icon
798
Tyler Technologies
TYL
$11.9B
-1,052
Closed -$607K
UPBD icon
799
Upbound Group
UPBD
$1.23B
-7,569
Closed -$221K
URI icon
800
United Rentals
URI
$70.9B
-45,829
Closed -$32.3M

Similar funds

Freestone Grove Partners's Q1 2025 Portfolio in Review

As of Q1 2025, Freestone Grove Partners held 829 positions worth $9.71B, up 19% from $8.16B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Freestone Grove Partners deployed $1.78B of net new capital in Q1 2025, opening 260 new positions and adding to 164 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 915,148 shares worth $470M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 16% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $588M trimmed.

  • Freestone Grove Partners's largest Q1 2025 buy was Vanguard S&P 500 ETF: 915,148 shares worth $470M.
  • Freestone Grove Partners added most to Lam Research in Q1 2025, an estimated $97.7M increase.
  • Freestone Grove Partners's biggest Q1 2025 reduction was iShares Core S&P 500 ETF, cutting an estimated $588M.
  • Freestone Grove Partners fully exited Alphabet (Google) Class A in Q1 2025, selling an estimated $111M.
  • Freestone Grove Partners's ten largest holdings make up 16% of its $9.71B portfolio in Q1 2025.
  • Freestone Grove Partners opened 260 new positions and closed 261 in Q1 2025.
  • Freestone Grove Partners's portfolio value rose 19% quarter-over-quarter to $9.71B.

Based on Freestone Grove Partners's 13F filing for Q1 2025, filed 15 May 2025.